Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:11:12 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



News for C:BLCO from 2023-05-02 to 2024-05-01 - 44 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-05-01 09:56C:BLCOBausch + Lomb Corp19.92News ReleaseBausch + Lomb loses $163-million in Q1 2024
2024-04-25 12:39C:BLCOBausch + Lomb Corp20.34News ReleaseBausch + Lomb's NutriTears study meets end points
2024-04-23 08:14C:BLCOBausch + Lomb Corp20.31In the NewsGlobe says Bausch + Lomb maintained at "outperform"
2024-04-18 12:06C:BLCOBausch + Lomb Corp19.66News ReleaseBausch + Lomb takes a bow for recycling programs
2024-04-15 15:48C:BLCOBausch + Lomb Corp19.73News ReleaseBausch + Lomb to release Q1 2024 results May 1
2024-02-28 13:13C:BLCOBausch + Lomb Corp22.98News ReleaseBausch + Lomb appoints Ling as director
2024-02-23 07:51C:BLCOBausch + Lomb Corp23.34In the NewsGlobe says Bausch + Lomb maintained at "buy"
2024-02-21 18:57C:BLCOBausch + Lomb Corp22.47SEDAR Annual Information FormSEDAR Annual Information Form
2024-02-21 18:57C:BLCOBausch + Lomb Corp22.47SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-21 18:57C:BLCOBausch + Lomb Corp22.47SEDAR MD & ASEDAR MD & A
2024-02-21 09:19C:BLCOBausch + Lomb Corp19.74News ReleaseBausch + Lomb loses $248-million in 2023
2024-02-09 08:16C:BLCOBausch + Lomb Corp18.88In the NewsGlobe says Miehm keeps Bausch + Lomb at "outperform"
2024-02-05 12:55C:BLCOBausch + Lomb Corp18.81News ReleaseBausch + Lomb to release 2023 results Feb. 21
2024-01-15 08:05C:BLCOBausch + Lomb Corp19.80In the NewsGlobe says McElvaine Value doing well my Maxim, others
2024-01-08 09:21C:BLCOBausch + Lomb Corp21.22News ReleaseBausch + Lomb receives FDA OK for TENEO excimer laser
2023-11-29 07:26C:BLCOBausch + Lomb Corp21.31In the NewsGlobe says tougher FX headwinds seen at Bausch + Lomb
2023-11-15 12:15C:BLCOBausch + Lomb Corp21.67News ReleaseBausch + Lomb collects 76.64 M units of lenses in U.S.
2023-11-01 17:22C:BLCOBausch + Lomb Corp22.91SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-01 17:20C:BLCOBausch + Lomb Corp22.91SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-01 09:38C:BLCOBausch + Lomb Corp22.26News ReleaseBausch + Lomb loses $80-million in Q3 2023
2023-10-24 09:09C:BLCOBausch + Lomb Corp23.08In the NewsGlobe says Miehm keeping Bausch + Lomb at "outperform"
2023-10-16 16:08C:BLCOBausch + Lomb Corp22.27News ReleaseBausch + Lomb to release Q3 results, host call Nov. 1
2023-09-29 10:20C:BLCOBausch + Lomb Corp23.08News ReleaseBausch + Lomb completes acquisition of Xiidra
2023-09-26 09:25C:BLCOBausch + Lomb Corp23.04News ReleaseBausch + Lomb rolls out Lumify Eye line in U.S.
2023-09-14 17:33C:BLCOBausch + Lomb Corp23.94News ReleaseBausch + Lomb prices $1.4-billion note offering
2023-09-12 10:05C:BLCOBausch + Lomb Corp23.87News ReleaseBausch + Lomb rolls out Miebo eye drops in U.S.
2023-09-11 09:05C:BLCOBausch + Lomb Corp23.87News ReleaseBausch + Lomb arranges $1.4B financing for Xiidra buy
2023-09-06 18:04C:BLCOBausch + Lomb Corp24.16News ReleaseBausch + Lomb discloses historical info for Xiidra buy
2023-08-24 09:36C:BLCOBausch + Lomb Corp26.59News ReleaseBausch + Lomb's Xiidra deal waiting period expires
2023-08-02 16:42C:BLCOBausch + Lomb Corp25.38SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-02 11:16C:BLCOBausch + Lomb Corp25.38News ReleaseBausch + Lomb loses $32-million in Q2 2023
2023-08-01 11:32C:BLCOBausch + Lomb Corp26.21News ReleaseBausch + Lomb appoints Gevgilili as EVP, HR officer
2023-07-11 11:43C:BLCOBausch + Lomb Corp26.08News ReleaseBausch + Lomb to release Q2 2023 results Aug. 2
2023-07-06 09:39C:BLCOBausch + Lomb Corp26.19News ReleaseBausch + Lomb acquires Blink product line for $106.5M
2023-06-30 18:50C:BLCOBausch + Lomb Corp26.52News ReleaseBausch + Lomb to acquire dry eye drug Xiidra for $2.5B
2023-06-12 10:04C:BLCOBausch + Lomb Corp25.23News ReleaseBausch + Lomb rolls outs PreserVision AREDS 2 in U.S.
2023-06-08 09:46C:BLCOBausch + Lomb Corp24.57News ReleaseBausch + Lomb to detail new data at AOA virtual event
2023-06-06 10:41C:BLCOBausch + Lomb Corp24.62News ReleaseBausch + Lomb rolls out Biotrue hydration boost in U.S.
2023-06-05 09:43C:BLCOBausch + Lomb Corp24.57News ReleaseBausch + Lomb rolls out Infuse contact lenses in U.S.
2023-06-01 09:22C:BLCOBausch + Lomb Corp24.27News ReleaseBausch + Lomb makes changes to executive leadership
2023-05-18 14:12C:BLCOBausch + Lomb Corp26.23News ReleaseBausch + Lomb, Novaliq receive FDA OK for Miebo
2023-05-03 17:46C:BLCOBausch + Lomb Corp24.23SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-03 17:46C:BLCOBausch + Lomb Corp24.23SEDAR MD & ASEDAR MD & A
2023-05-03 09:51C:BLCOBausch + Lomb Corp24.23News ReleaseBausch + Lomb loses $88-million in 2022